BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 26330360)

  • 21. KAP1 is associated with peritoneal carcinomatosis in gastric cancer.
    Yokoe T; Toiyama Y; Okugawa Y; Tanaka K; Ohi M; Inoue Y; Mohri Y; Miki C; Kusunoki M
    Ann Surg Oncol; 2010 Mar; 17(3):821-8. PubMed ID: 19898899
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gene expression changes induced by HIPEC in a murine model of gastric cancer.
    Graziosi L; Mencarelli A; Renga B; Santorelli C; Cantarella F; Bugiantella W; Cavazzoni E; Donini A; Fiorucci S
    In Vivo; 2012; 26(1):39-45. PubMed ID: 22210714
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epigenetic modulation and repression of miR-200b by cancer-associated fibroblasts contribute to cancer invasion and peritoneal dissemination in gastric cancer.
    Kurashige J; Mima K; Sawada G; Takahashi Y; Eguchi H; Sugimachi K; Mori M; Yanagihara K; Yashiro M; Hirakawa K; Baba H; Mimori K
    Carcinogenesis; 2015 Jan; 36(1):133-41. PubMed ID: 25411357
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transduction of soluble Flt-1 gene to peritoneal mesothelial cells can effectively suppress peritoneal metastasis of gastric cancer.
    Sako A; Kitayama J; Koyama H; Ueno H; Uchida H; Hamada H; Nagawa H
    Cancer Res; 2004 May; 64(10):3624-8. PubMed ID: 15150121
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High-level expression of S100A4 correlates with lymph node metastasis and poor prognosis in patients with gastric cancer.
    Wang YY; Ye ZY; Zhao ZS; Tao HQ; Chu YQ
    Ann Surg Oncol; 2010 Jan; 17(1):89-97. PubMed ID: 19820999
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mechanisms of peritoneal metastasis after operation for non-serosa-invasive gastric carcinoma: an ultrarapid detection system for intraperitoneal free cancer cells and a prophylactic strategy for peritoneal metastasis.
    Marutsuka T; Shimada S; Shiomori K; Hayashi N; Yagi Y; Yamane T; Ogawa M
    Clin Cancer Res; 2003 Feb; 9(2):678-85. PubMed ID: 12576435
    [TBL] [Abstract][Full Text] [Related]  

  • 27. ICAM-2 gene therapy for peritoneal dissemination of scirrhous gastric carcinoma.
    Tanaka H; Yashiro M; Sunami T; Sakate Y; Kosaka K; Hirakawa K
    Clin Cancer Res; 2004 Jul; 10(14):4885-92. PubMed ID: 15269165
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic significance of osteopontin expression in human gastric carcinoma.
    Higashiyama M; Ito T; Tanaka E; Shimada Y
    Ann Surg Oncol; 2007 Dec; 14(12):3419-27. PubMed ID: 17896150
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The metastasis-associated microRNA miR-516a-3p is a novel therapeutic target for inhibiting peritoneal dissemination of human scirrhous gastric cancer.
    Takei Y; Takigahira M; Mihara K; Tarumi Y; Yanagihara K
    Cancer Res; 2011 Feb; 71(4):1442-53. PubMed ID: 21169410
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Overexpression of RegIV in peritoneal dissemination of gastric cancer and its potential as A novel marker for the detection of peritoneal micrometastasis.
    Miyagawa K; Sakakura C; Nakashima S; Yoshikawa T; Fukuda K; Kin S; Nakase Y; Shimomura K; Oue N; Yasui W; Hayasizaki H; Okazaki Y; Yamagishi H; Hagiwara A; Otsuji E
    Anticancer Res; 2008; 28(2B):1169-79. PubMed ID: 18505053
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Integrative identification of Epstein-Barr virus-associated mutations and epigenetic alterations in gastric cancer.
    Liang Q; Yao X; Tang S; Zhang J; Yau TO; Li X; Tang CM; Kang W; Lung RW; Li JW; Chan TF; Xing R; Lu Y; Lo KW; Wong N; To KF; Yu C; Chan FK; Sung JJ; Yu J
    Gastroenterology; 2014 Dec; 147(6):1350-62.e4. PubMed ID: 25173755
    [TBL] [Abstract][Full Text] [Related]  

  • 32. βig-h3 CORRELATES WITH RELATED FACTORS OF PERITONEAL METASTASIS OF GASTRIC CANCER.
    Wang F; Li XW; Lu WB; Jin JH
    J Biol Regul Homeost Agents; 2015; 29(1):181-6. PubMed ID: 25864756
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quantitative proteomic and genomic profiling reveals metastasis-related protein expression patterns in gastric cancer cells.
    Chen YR; Juan HF; Huang HC; Huang HH; Lee YJ; Liao MY; Tseng CW; Lin LL; Chen JY; Wang MJ; Chen JH; Chen YJ
    J Proteome Res; 2006 Oct; 5(10):2727-42. PubMed ID: 17022644
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of PRL-3 gene expression in gastric cancer cell line SGC7901 via microRNA suppressed reduces peritoneal metastasis.
    Li Z; Zhan W; Wang Z; Zhu B; He Y; Peng J; Cai S; Ma J
    Biochem Biophys Res Commun; 2006 Sep; 348(1):229-37. PubMed ID: 16875667
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [IGFBP-2 mRNA expression in gastric cancer tissues and its roles in proliferation, differentiation and peritoneal metastasis of gastric cancer].
    He T; Wu XT; Yang ZM; Da MX; Zhang MM; Qian K
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2005 Mar; 36(2):187-9. PubMed ID: 15807262
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Nobel genes improve accuracy in detection of peritoneal micro-metastasis of gastric cancer to decide indication for chemotherapy].
    Shimomura K; Ohgaki M; Kakihara N; Matsumura H; Miyata K; Iizuka R; Ikawa W; Shimotsuma M; Takenaka A; Sakakura C; Hagiwara A; Yamagishi H
    Gan To Kagaku Ryoho; 2004 Oct; 31(11):1912-4. PubMed ID: 15553757
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic significance of MAGE in peritoneal washes in gastric carcinoma patients without peritoneal metastasis: results of a 5-year follow-up study.
    Jeon CH; Shin IH; Park JB; Chae HD
    J Clin Gastroenterol; 2010; 44(10):682-6. PubMed ID: 20421806
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multiplex profiling of peritoneal metastases from gastric adenocarcinoma identified novel targets and molecular subtypes that predict treatment response.
    Wang R; Song S; Harada K; Ghazanfari Amlashi F; Badgwell B; Pizzi MP; Xu Y; Zhao W; Dong X; Jin J; Wang Y; Scott A; Ma L; Huo L; Vicente D; Blum Murphy M; Shanbhag N; Tatlonghari G; Thomas I; Rogers J; Kobayashi M; Vykoukal J; Estrella JS; Roy-Chowdhuri S; Han G; Zhang S; Mao X; Song X; Zhang J; Gu J; Johnson RL; Calin GA; Peng G; Lee JS; Hanash SM; Futreal A; Wang Z; Wang L; Ajani JA
    Gut; 2020 Jan; 69(1):18-31. PubMed ID: 31171626
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Carcinoembryonic antigen mRNA in abdominal cavity as a useful predictor of peritoneal recurrence of gastric cancer with serosal exposure.
    Fujii S; Kitayama J; Kaisaki S; Sasaki S; Seto Y; Tominaga O; Tsuno N; Umetani N; Yokota H; Kitamura K; Tsuruo T; Nagawa H
    J Exp Clin Cancer Res; 2002 Dec; 21(4):547-53. PubMed ID: 12636101
    [TBL] [Abstract][Full Text] [Related]  

  • 40. REGIV as a potential biomarker for peritoneal dissemination in gastric adenocarcinoma.
    Moon JH; Fujiwara Y; Nakamura Y; Okada K; Hanada H; Sakakura C; Takiguchi S; Nakajima K; Miyata H; Yamasaki M; Kurokawa Y; Mori M; Doki Y
    J Surg Oncol; 2012 Feb; 105(2):189-94. PubMed ID: 21780125
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.